Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
RD-0605 in Crohn Disease: NCT07309744 Clinical Landscape Report 2026
16 October 2026
NCT07309744 clinical landscape for Crohn Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pucotenlimab in Pancreatic Cancer: NCT07312422 Clinical Landscape Report 2026
16 October 2026
NCT07312422 clinical landscape for Pancreatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Angiotensin II Acetate in Hepatocellular Carcinoma: NCT07312292 Clinical Landscape Report 2026
16 October 2026
NCT07312292 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
NH-002(Trust Bio-sonics) in Pancreatic adenocarcinoma metastatic: NCT07314385 Clinical Landscape Report 2026
16 October 2026
NCT07314385 clinical landscape for Pancreatic adenocarcinoma metastatic: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Hydromorphone Hydrochloride in Analgesia: NCT07315022 Clinical Landscape Report 2026
16 October 2026
NCT07315022 clinical landscape for Analgesia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tislelizumab in Hepatocellular Carcinoma: NCT07328009 Clinical Landscape Report 2026
16 October 2026
NCT07328009 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Mufemilast in Pulmonary Disease, Chronic Obstructive: NCT07314242 Clinical Landscape Report 2026
16 October 2026
NCT07314242 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
Apatinib Mesylate in Unresectable Hepatocellular Carcinoma: NCT07314372 Clinical Landscape Report 2026
16 October 2026
NCT07314372 clinical landscape for Unresectable Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Atezolizumab in Advanced Hepatocellular Carcinoma: NCT07317414 Clinical Landscape Report 2026
16 October 2026
NCT07317414 clinical landscape for Advanced Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Apatinib Mesylate in Unresectable Hepatocellular Carcinoma: NCT07324473 Clinical Landscape Report 2026
16 October 2026
NCT07324473 clinical landscape for Unresectable Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Atomoxetine Hydrochloride in Parkinson Disease: NCT07316296 Clinical Landscape Report 2026
16 October 2026
NCT07316296 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
NWRD06 in Hepatocellular Carcinoma: NCT07324304 Clinical Landscape Report 2026
16 October 2026
NCT07324304 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.